Ridaforolimus
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-dimethylphosphoryloxy-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
Molecular Identity
Ridaforolimus
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-dimethylphosphoryloxy-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
PubChem CID: 11520894
2D Structure
Properties
C53H84NO14P
Molecular Formula
990.20
Molecular Weight
g/mol
989.5629
Exact Mass
Da
5.9
XLogP
Above Lipinski threshold
202
TPSA
May have limited oral absorption
2
H-Bond Donors
14
H-Bond Acceptors
1940
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
RidaforolimusDeforolimus572924-54-0AP23573MK-8669AP-23573MK866948Z35KB15KDTXSID001025942Rapamycin, 42-(dimethylphosphinate)ridaforolimusumMK 8669CHEBI:82677RefChem:179414L01XE19
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Ridaforolimus
Loading drug network...